Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2581 to 2595 of 7685 results

  1. Pulsed field ablation for atrial fibrillation

    In development [GID-IPG10267] Expected publication date: 14 August 2025

    Interventional procedures guidance
    In development

  2. Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia

    In development [GID-IPG10268] Expected publication date: 08 January 2025

    Interventional procedures guidance
    In development

  3. Noninvasive Vagus Nerve Stimulation For reactive airway disease

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  4. Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)

    In development [GID-NG10216] Expected publication date: TBC

    NICE guideline
    In development

  5. Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)

    Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the Rapid fetal fibronectin (fFN) 10Q Cassette Kit (at thresholds other than 50 nanograms/millilitre)

    Diagnostics guidance
    Published
    4 July 2018
    View recommendations

    Sections for DG33

  6. Triheptanoin for treating long-chain fatty acid oxidation disorders ID3891

    In development [GID-TA11473] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency ID6415

    In development [GID-TA11503] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development

  8. Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]

      Status ...

    Technology appraisal guidance
    Topic selection

  9. Digital technologies to support self-management of COPD: early value assessment

    In development [GID-HTE10030] Expected publication date: 19 December 2024

    Health technology evaluations
    In development

  10. Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462

    In development [GID-TA11602] Expected publication date: 11 September 2025

    Technology appraisal guidance
    In development

  11. Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment: draft guidance

    We are listening to your views on this Health technology evaluation. Comments close 17 December 2024.

    Health technology evaluation
    In consultation

  12. Non-alcoholic fatty liver disease (NAFLD): assessment and management

    In development [GID-NG10434] Expected publication date: TBC

    NICE guideline
    In development

  13. Intrapartum Care - maternal hyponatremia

    In development [GID-NG10431] Expected publication date: 26 March 2025

    NICE guideline
    In development

  14. Tirzepatide for managing overweight and obesity [ID6179]

    In development [GID-TA11156] Expected publication date: 14 January 2025

    Technology appraisal guidance
    In development

  15. Digital technologies to support smoking cessation in secondary care patients: early value assessment

    Awaiting development [GID-HTE10061] Expected publication date: TBC

    Health technology evaluations
    Awaiting development